Humacyte, Inc. (HUMA) Tops Q2 EPS by 57c

Humacyte, Inc. (NASDAQ: HUMA) reported Q2 EPS of $0.35, $0.57 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $235.4 thousand.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• KB Home (KBH) PT Raised to $56 at Truist Securities